Skip to main content
OpenTrials

Clinical trial condition

Thymus Neoplasms

Explore clinical trials studying Thymus Neoplasms. Study availability and eligibility vary by location and protocol.

72 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Thymus Neoplasms trial results

Completed

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00020579

Conditions
AIDS-related Kaposi sarcoma, Adenocarcinoma, Adenoma, +214 more
Locations
  • National Naval Medical Center Bethesda, Maryland, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • NCI - Center for Cancer Research Bethesda, Maryland, United States
View Trial Details
Completed

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

NCT00003662

Conditions
Anemia, Anemia, Refractory, Bone Marrow Diseases, +16 more
Locations
  • University of Florida Health Science Center Gainesville, Florida, United States
  • Division of Pediatric Surgery Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

NCT06790706

Conditions
Adenocarcinoma, Anaplastic Thyroid Carcinomas, Carcinoid Tumor, +27 more
Locations
  • Institut de Cancerologie de l'Ouest , medical oncology department Angers, France
  • Institut Bergonié, medical oncology department Bordeaux, France
  • Hospices Civils de Lyon, Thoracic Oncology Department, Louis Pradel Hospital Bron, France
  • Centre Hospitalier Universitaire de Lille, medical oncology department Lille, France
View all 15 locations
View Trial Details
Active, Not Recruiting

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

NCT01025089

Conditions
Clinical Masaoka Stage II to IVA, Hemic and Lymphatic Diseases, Lymphatic Diseases, +8 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering West Harrison Harrison, New York, United States
View Trial Details

Related conditions